- Home
- SBGI vs IMNM Comparison
SBGI vs IMNM Comparison
Compare SBGI & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBGI
- IMNM
- Stock Information
- Founded
- SBGI 1986
- IMNM 2006
- Country
- SBGI United States
- IMNM United States
- Employees
- SBGI N/A
- IMNM 155
- Industry
- SBGI Broadcasting
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- SBGI Industrials
- IMNM Health Care
- Exchange
- SBGI Nasdaq
- IMNM Nasdaq
- Market Cap
- SBGI 970.9M
- IMNM 1.2B
- IPO Year
- SBGI 1995
- IMNM 2020
- Fundamental
- Price
- SBGI $13.09
- IMNM $14.25
- Analyst Decision
- SBGI Buy
- IMNM Strong Buy
- Analyst Count
- SBGI 5
- IMNM 9
- Target Price
- SBGI $20.80
- IMNM $24.89
- AVG Volume (30 Days)
- SBGI 463.1K
- IMNM 1.9M
- Earning Date
- SBGI 11-05-2025
- IMNM 11-12-2025
- Dividend Yield
- SBGI 7.54%
- IMNM N/A
- EPS Growth
- SBGI N/A
- IMNM N/A
- EPS
- SBGI 0.74
- IMNM N/A
- Revenue
- SBGI $3,481,000,000.00
- IMNM $12,589,000.00
- Revenue This Year
- SBGI N/A
- IMNM N/A
- Revenue Next Year
- SBGI $9.50
- IMNM $140.06
- P/E Ratio
- SBGI $17.91
- IMNM N/A
- Revenue Growth
- SBGI 8.11
- IMNM 16.74
- 52 Week Low
- SBGI $11.89
- IMNM $5.15
- 52 Week High
- SBGI $18.46
- IMNM $15.13
- Technical
- Relative Strength Index (RSI)
- SBGI 33.98
- IMNM 67.64
- Support Level
- SBGI $13.00
- IMNM $13.49
- Resistance Level
- SBGI $14.33
- IMNM $14.75
- Average True Range (ATR)
- SBGI 0.46
- IMNM 0.99
- MACD
- SBGI -0.18
- IMNM 0.25
- Stochastic Oscillator
- SBGI 8.44
- IMNM 87.43
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.